Tag Archives: Atomwise

September 26, 2019
In The News

Science Daily reports on a recent publication by researchers at Stanford, Mayo Clinic, and Atomwise.

Read Article
September 11, 2019
Press Release

Atomwise could receive up to US$1.5 billion to develop first in-class and best in-class small molecules through partnership with China’s leading biopharmaceutical company, Hansoh Pharma.

Read Article
September 11, 2019
In The News

Mark Terry of BioSpace reports on Atomwise’s three new joint ventures.

Read Article
September 11, 2019
Press Release

Atomwise and Atropos Therapeutics form a joint venture to discover and develop anticancer agents using senescence assay and AI technologies.

Read Article
September 10, 2019
In The News

Connor Hale at FierceBiotech writes about Atomwise’s new joint ventures with SEngine Precision Medicine and OncoStatyx.

Read Article
September 10, 2019
Press Release

Joint venture brings together AI technology and living tumor organoids to develop novel personalized therapies for cancer patients SEATTLE, Wash., and SAN FRANCISCO, Calif. – SEngine Precision Medicine and Atomwise, Inc. today announced a joint venture to accelerate novel oncology drug discovery utilizing the unique platform technologies each company has validated through years of development. […]

Read Article